Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
暂无分享,去创建一个
David L. Page | D. Page | R. Jensen | J. Holt | Roy A. Jensen | Marilyn E. Thompson | Patrice S. Obermiller | Jeffrey T. Holt | M. E. Thompson | P. S. Obermiller
[1] A. Nienhuis,et al. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation , 1988, Molecular and cellular biology.
[2] T. Akiyama,et al. :A long term follow-up study , 1982 .
[3] H. Soule,et al. Estrogen responsive proliferation of clonal human breast carcinoma cells in athymic mice. , 1980, Cancer letters.
[4] D. Page,et al. Identification of genes expressed in premalignant breast disease by microscopy-directed cloning. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[5] A. Whittemore,et al. An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.
[6] H. Nevanlinna,et al. Evidence for involvement of BRCA1 in sporadic breast carcinomas. , 1994, Cancer research.
[7] Francis S. Collins,et al. Mutations in the BRCA1 gene in families with early-onset breast and ovarian cancer , 1994, Nature Genetics.
[8] R. Bast,et al. A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. , 1993, Cancer research.
[9] Y. Nakamura,et al. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. , 1993, Cancer research.
[10] W. Dupont,et al. Intraductal carcinoma of the breast: Follow‐up after biopsy only , 1982, Cancer.
[11] D. Page,et al. Pathology and heredity of breast cancer in younger women. , 1994, Journal of the National Cancer Institute. Monographs.
[12] M. Chalfie,et al. Cooperative interactions between the Caenorhabditis elegans homeoproteins UNC-86 and MEC-3. , 1993, Science.
[13] P. Rosen,et al. Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. , 1978 .
[14] J. Rommens,et al. Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families , 1994, Nature Genetics.
[15] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[16] M. King,et al. Linkage of early-onset familial breast cancer to chromosome 17q21. , 1990, Science.
[17] David L. Page,et al. Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study , 1985, Cancer.
[18] M. Scott,et al. Homeotic genes regulate the spatial expression of putative growth factors in the visceral mesoderm of Drosophila embryos. , 1990, Development.
[19] S. Neuhausen,et al. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds. , 1994, Cancer Research.
[20] Patrick Dowd,et al. Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families , 1994, Nature Genetics.
[21] F. Collins,et al. Somatic mutations in the BRCA1 gene in sporadic ovarian tumours , 1995, Nature Genetics.
[22] W. Dupont,et al. Anatomic markers of human premalignancy and risk of breast cancer , 1990, Cancer.